有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | [2-Oxo-2-(propan-2-ylamino)ethyl] 2-[(4-benzyl-5-cyclopropyl-1,2,4-triazol-3-yl)sulfanyl]acetate | —— | C19H24N4O3S |
|
—— | 4-cyclopropyl-3-[(2S)-2-phenylpropyl]sulfanyl-1,2,4-triazole | —— | C14H17N3S |
|
—— | 4-cyclopropyl-3-[(2R)-2-phenylpropyl]sulfanyl-1,2,4-triazole | —— | C14H17N3S |
|
—— | [2-(Cyclohexylamino)-2-oxoethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C16H20BrNO3S |
|
—— | [2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C18H18BrNO3S |
|
—— | [2-(Furan-2-ylmethylamino)-2-oxoethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C15H14BrNO4S |
|
—— | [2-(Tert-butylamino)-2-oxoethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C14H18BrNO3S |
|
—— | [2-[[(2S)-3-methylbutan-2-yl]amino]-2-oxoethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C15H20BrNO3S |
|
—— | [2-Oxo-2-(pentan-3-ylamino)ethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C15H20BrNO3S |
|
—— | (2-Thiophen-2-yl-1,3-oxazol-4-yl)methyl 2-(4-bromophenyl)sulfanylacetate | —— | C16H12BrNO3S2 |
|
—— | [(2R)-1-amino-1-oxopropan-2-yl] 2-(4-bromophenyl)sulfanylacetate | —— | C11H12BrNO3S |
|
—— | [2-Oxo-2-(thiophen-2-ylmethylamino)ethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C15H14BrNO3S2 |
|
—— | [(2S)-1-amino-1-oxopropan-2-yl] 2-(4-bromophenyl)sulfanylacetate | —— | C11H12BrNO3S |
|
—— | [2-(Benzylamino)-2-oxoethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C17H16BrNO3S |
|
—— | [2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C18H18BrNO3S |
|
—— | [2-[(1-Methylpyrrole-2-carbonyl)amino]-2-oxoethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C16H15BrN2O4S |
|
—— | [2-(Cyclopropylamino)-2-oxoethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C13H14BrNO3S |
|
—— | (2-Amino-2-oxoethyl) 2-(4-bromophenyl)sulfanylacetate | —— | C10H10BrNO3S |
|
—— | N-[(3S)-1-(2-morpholin-4-ylethyl)pyrrolidin-3-yl]-2-phenylsulfanylacetamide | —— | C18H27N3O2S |
|
—— | [2-[[(1R,2S)-2-methylcyclohexyl]amino]-2-oxoethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C17H22BrNO3S |
|
—— | N-[(3R)-1-(2-morpholin-4-ylethyl)pyrrolidin-3-yl]-2-phenylsulfanylacetamide | —— | C18H27N3O2S |
|
—— | [2-[[(1R,2R)-2-methylcyclohexyl]amino]-2-oxoethyl] 2-(4-bromophenyl)sulfanylacetate | —— | C17H22BrNO3S |
|
—— | 4-amino-2-[(S)-cyano(cyclohexyl)methyl]sulfanylpyrimidine-5-carbonitrile | —— | C13H15N5S |
|
—— | (2S)-2-cyclohexyl-2-[1-(2,2,2-trifluoroethyl)tetrazol-5-yl]sulfanylacetonitrile | —— | C11H14F3N5S |
|
—— | (2R)-2-(4-amino-6-methylpyrimidin-2-yl)sulfanyl-2-cyclohexylacetonitrile | —— | C13H18N4S |
|
—— | (2S)-2-cyclohexyl-2-[[5-(thiophen-2-ylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetonitrile | —— | C15H17N3OS2 |
|
—— | (2R)-2-cyclohexyl-2-[[4-(3-methoxypropyl)-5-oxo-1H-1,2,4-triazol-3-yl]sulfanyl]acetonitrile | —— | C14H22N4O2S |
|
—— | (2R)-2-cyclohexyl-2-[1-[[(2R)-oxolan-2-yl]methyl]tetrazol-5-yl]sulfanylacetonitrile | —— | C14H21N5OS |
|
—— | (2S)-2-cyclohexyl-2-[[4-(3-methoxypropyl)-5-oxo-1H-1,2,4-triazol-3-yl]sulfanyl]acetonitrile | —— | C14H22N4O2S |
|
—— | (2R)-2-cyclohexyl-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetonitrile | —— | C11H15N3S3 |
|
—— | (2S)-2-cyclohexyl-2-[(4-propan-2-yl-1,2,4-triazol-3-yl)sulfanyl]acetonitrile | —— | C13H20N4S |
|
—— | (2R)-2-cyclohexyl-2-[[5-(thiophen-2-ylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetonitrile | —— | C15H17N3OS2 |
|
—— | (2R)-2-cyclohexyl-2-[1-[[(2S)-oxolan-2-yl]methyl]tetrazol-5-yl]sulfanylacetonitrile | —— | C14H21N5OS |
|
—— | 2-[3-[(R)-cyano(cyclohexyl)methyl]sulfanyl-5-methyl-1,2,4-triazol-4-yl]acetamide | —— | C13H19N5OS |
|
—— | (2S)-2-cyclohexyl-2-[1-[[(2S)-oxolan-2-yl]methyl]tetrazol-5-yl]sulfanylacetonitrile | —— | C14H21N5OS |
|
—— | (2R)-2-cyclohexyl-2-[(4-propan-2-yl-1,2,4-triazol-3-yl)sulfanyl]acetonitrile | —— | C13H20N4S |
|
—— | (2S)-2-(4-amino-6-methylpyrimidin-2-yl)sulfanyl-2-cyclohexylacetonitrile | —— | C13H18N4S |
|
—— | (2R)-2-cyclohexyl-2-[[4-(2-pyridin-2-ylethyl)-1,2,4-triazol-3-yl]sulfanyl]acetonitrile | —— | C17H21N5S |
|
—— | (2S)-2-cyclohexyl-2-[[4-(2-pyridin-2-ylethyl)-1,2,4-triazol-3-yl]sulfanyl]acetonitrile | —— | C17H21N5S |
|
—— | 2-[3-[(S)-cyano(cyclohexyl)methyl]sulfanyl-5-methyl-1,2,4-triazol-4-yl]acetamide | —— | C13H19N5OS |
|
—— | (2R)-2-cyclohexyl-2-[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylacetonitrile | —— | C13H22N6S |
|
—— | N-[(2S)-2-(2-chloro-6-fluorophenyl)-2-[(2R)-2-methylmorpholin-4-yl]ethyl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide | —— | C21H26ClFN4O2S |
|
—— | N-[(2R)-2-(2-chloro-6-fluorophenyl)-2-[(2R)-2-methylmorpholin-4-yl]ethyl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide | —— | C21H26ClFN4O2S |
|
—— | (2R)-2-ethylsulfonyl-N-(2-methylbutan-2-yl)propanamide | —— | C10H21NO3S |
|
—— | (2S)-2-ethylsulfonyl-N-(4-methylcyclohexyl)propanamide | —— | C12H23NO3S |
|
—— | (2S)-2-ethylsulfonyl-N-(2-methylpropyl)propanamide | —— | C9H19NO3S |
|
—— | (2R)-2-ethylsulfonyl-N-[(1S,2S)-2-methylcyclohexyl]propanamide | —— | C12H23NO3S |
|
—— | (2R)-N-(2-methylbutan-2-yl)-2-methylsulfonylpropanamide | —— | C9H19NO3S |
|
—— | (2S)-N-cyclohexyl-2-ethylsulfonylpropanamide | —— | C11H21NO3S |
|
—— | (2S)-N-(cyclohexylmethyl)-2-ethylsulfonylpropanamide | —— | C12H23NO3S |
|